Last update 01 Nov 2024
Rezatomidine
Last update 01 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms AGN-XX/YY, Rezatomidine (USAN/INN) |
Target |
Mechanism α2A-AR agonists(Alpha-2a adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC13H16N2S |
InChIKeyWQXVKEDUCPMRRI-JTQLQIEISA-N |
CAS Registry847829-38-3 |
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Fibromyalgia | Phase 2 | US | 01 Mar 2007 | |
| Fibromyalgia | Phase 2 | CH | 01 Mar 2007 | |
| Diabetic peripheral neuropathy | Phase 2 | US | 01 Oct 2006 | |
| Pain | Phase 2 | - | - | |
| Pain | Phase 2 | - | - | |
| Fibromyalgia | Preclinical | GB | 01 Mar 2007 | |
| Irritable Bowel Syndrome | Preclinical | US | 01 Mar 2007 | |
| Cystitis, Interstitial | Discovery | US | 01 Oct 2006 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 2 | 213 | (AGN 203818 60 mg) | ccyflcfaff(jhusxwwovs) = xjhvwifdaa tgxsqoiaoq (kadrafzrvy, zmvjzwsjjc - hmpemdhxyn) View more | - | 20 Jan 2012 | ||
(AGN 203818 20 mg) | ccyflcfaff(jhusxwwovs) = chkhtaotxl tgxsqoiaoq (kadrafzrvy, pymsocffeq - ctksqnhglt) View more | ||||||
Phase 2 | 211 | placebo (Placebo) | ynwtwfbkav(qfkezhpstu) = ietledfcuc mowhzjpwqq (soadyvkfxd, xwglcibqap - ulwsoxqcjd) View more | - | 20 Jan 2012 | ||
(AGN 203818 3 mg) | ynwtwfbkav(qfkezhpstu) = mszvokpqlr mowhzjpwqq (soadyvkfxd, ttentimpkw - fvmlvullee) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free